OPKO Health Gross Profit 2010-2025 | OPK
OPKO Health gross profit from 2010 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
| OPKO Health Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $219 |
| 2023 | $318 |
| 2022 | $288 |
| 2021 | $582 |
| 2020 | $541 |
| 2019 | $329 |
| 2018 | $386 |
| 2017 | $346 |
| 2016 | $506 |
| 2015 | $256 |
| 2014 | $43 |
| 2013 | $48 |
| 2012 | $19 |
| 2011 | $11 |
| 2010 | $15 |
| 2009 | $2 |
| OPKO Health Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2025-03-31 | $43 |
| 2024-12-31 | $85 |
| 2024-09-30 | $40 |
| 2024-06-30 | $52 |
| 2024-03-31 | $42 |
| 2023-12-31 | $45 |
| 2023-09-30 | $48 |
| 2023-06-30 | $126 |
| 2023-03-31 | $99 |
| 2022-12-31 | $56 |
| 2022-09-30 | $31 |
| 2022-06-30 | $116 |
| 2022-03-31 | $85 |
| 2021-12-31 | $109 |
| 2021-09-30 | $142 |
| 2021-06-30 | $150 |
| 2021-03-31 | $182 |
| 2020-12-31 | $176 |
| 2020-09-30 | $155 |
| 2020-06-30 | $139 |
| 2020-03-31 | $71 |
| 2019-12-31 | $82 |
| 2019-09-30 | $87 |
| 2019-06-30 | $82 |
| 2019-03-31 | $78 |
| 2018-12-31 | $72 |
| 2018-09-30 | $99 |
| 2018-06-30 | $114 |
| 2018-03-31 | $101 |
| 2017-12-31 | $4 |
| 2017-09-30 | $95 |
| 2017-06-30 | $135 |
| 2017-03-31 | $112 |
| 2016-12-31 | $12 |
| 2016-09-30 | $147 |
| 2016-06-30 | $204 |
| 2016-03-31 | $144 |
| 2015-12-31 | $133 |
| 2015-09-30 | $76 |
| 2015-06-30 | $28 |
| 2015-03-31 | $20 |
| 2014-12-31 | $14 |
| 2014-09-30 | $9 |
| 2014-06-30 | $11 |
| 2014-03-31 | $10 |
| 2013-12-31 | $9 |
| 2013-09-30 | $9 |
| 2013-06-30 | $11 |
| 2013-03-31 | $20 |
| 2012-12-31 | $7 |
| 2012-09-30 | $4 |
| 2012-06-30 | $4 |
| 2012-03-31 | $4 |
| 2011-12-31 | $2 |
| 2011-09-30 | $3 |
| 2011-06-30 | $4 |
| 2011-03-31 | $3 |
| 2010-12-31 | $8 |
| 2010-09-30 | $2 |
| 2010-06-30 | $3 |
| 2010-03-31 | $2 |
| 2009-12-31 | $0 |
| 2009-09-30 | $0 |
| 2009-06-30 | $1 |
| 2009-03-31 | $1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.079B | $0.713B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $199.191B | 87.25 |
| Thermo Fisher Scientific (TMO) | United States | $152.413B | 18.44 |
| Edwards Lifesciences (EW) | United States | $45.596B | 29.90 |
| Alcon (ALC) | Switzerland | $42.592B | 28.78 |
| IDEXX Laboratories (IDXX) | United States | $41.462B | 47.65 |
| DexCom (DXCM) | United States | $33.274B | 51.43 |
| IQVIA Holdings (IQV) | United States | $24.396B | 13.66 |
| Mettler-Toledo (MTD) | United States | $24.382B | 29.00 |
| STERIS (STE) | Ireland | $24.071B | 26.54 |
| Waters (WAT) | United States | $21.144B | 29.83 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.666B | 0.00 |
| Hologic (HOLX) | United States | $14.021B | 15.23 |
| Sysmex ADR (SSMXY) | Japan | $10.468B | 29.70 |
| Penumbra (PEN) | United States | $10.283B | 80.71 |
| Masimo (MASI) | United States | $8.511B | 31.39 |
| Globus Medical (GMED) | United States | $7.972B | 19.00 |
| Glaukos (GKOS) | United States | $5.421B | 0.00 |
| Teleflex (TFX) | United States | $5.414B | 8.94 |
| TransMedics (TMDX) | United States | $4.319B | 93.89 |
| Integer Holdings (ITGR) | United States | $4.169B | 21.84 |
| PROCEPT BioRobotics (PRCT) | United States | $3.082B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.354B | 14.02 |
| Veracyte (VCYT) | United States | $2.111B | 29.63 |
| Elekta AB (EKTAY) | Sweden | $2.106B | 18.93 |
| Nihon Kohden (NHNKY) | Japan | $2.054B | 23.56 |
| Alphatec Holdings (ATEC) | United States | $1.821B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.417B | 0.00 |
| Artivion (AORT) | United States | $1.269B | 118.84 |
| Pulse Biosciences (PLSE) | United States | $1.200B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.985B | 5.24 |
| SiBone (SIBN) | United States | $0.809B | 0.00 |
| IRadimed (IRMD) | United States | $0.739B | 37.51 |
| Beta Bionics (BBNX) | United States | $0.666B | 0.00 |
| RxSight (RXST) | United States | $0.660B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.594B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.585B | 9.09 |
| Mesa Laboratories (MLAB) | United States | $0.571B | 13.38 |
| AxoGen (AXGN) | United States | $0.496B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.494B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.447B | 11.89 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.442B | 0.00 |
| NeuroPace (NPCE) | United States | $0.430B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.406B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.369B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.335B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.312B | 0.00 |
| Neuronetics (STIM) | United States | $0.260B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.230B | 13.94 |
| Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
| 908 Devices (MASS) | United States | $0.210B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.182B | 0.00 |
| CVRx (CVRX) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.176B | 0.00 |
| Inogen (INGN) | United States | $0.176B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.164B | 0.00 |
| Accuray (ARAY) | United States | $0.163B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.163B | 0.00 |
| LENSAR (LNSR) | United States | $0.162B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.148B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.138B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.098B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.70 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.066B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Hyperfine (HYPR) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Spectral AI (MDAI) | United States | $0.042B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Envoy Medical (COCH) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.025B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.37 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |